ReviewInternational journal of high risk behaviors & addiction2015
Iran's Activities on Prevention, Treatment and Harm Reduction of Drug Abuse.
Review in International journal of high risk behaviors & addiction, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis.Harm reduction journal · 2021Pooled it
- A systematic review and meta-analysis of the prevalence of hepatitis C virus infection in people who inject drugs in Iran.BMC public health · 2020Pooled it
- Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis.Harm reduction journal · 2018Pooled it
- The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses.Scientific reports · 2018Pooled it
- A decade of change: trends in drug and alcohol use in Iran (2010-2019).BMC public health · 2026Article
- National and sub-national HIV/AIDS epidemiology, socioeconomic influences, and risk factors in Iran from 1990 to 2021, global burden of disease 2021 study.Scientific reports · 2025Article
- Burden of Substance Use Disorders in the Middle East and North Africa from 1990 to 2019.Balkan medical journal · 2025Article
- Seroepidemiological Investigation of Hepatitis B and C Prevalence and Associated Factors Among People in Custody at Zahedan Central Prison.Archives of Iranian medicine · 2024Article
- The factors affecting substance abuse relapse based on theory of planned behavior in male addicts covered by addiction treatment centers in Southern Iran.BMC public health · 2024Article
- Deaddicta® for maintenance treatment of Opioid-dependence: A six-month follow-up.Caspian journal of internal medicine · 2024Article
- Double counting of clients using services in Iran: implications for assessing the reach of harm reduction programs.Harm reduction journal · 2023Article
- Time Series Modeling and Forecasting of Drug-Related Deaths in Iran (2014-2016).Addiction & health · 2023Article
- Understanding injecting drug use in Afghanistan: A scoping review.Substance abuse treatment, prevention, and policy · 2022Article
- An on-site community-based model for hepatitis C screening, diagnosis, and treatment among people who inject drugs in Kerman, Iran: The Rostam study.The International journal on drug policy · 2022Article
- Lapse and Relapse Rates in Narcotics Anonymous versus Methadone Maintenance Treatment: A 12-Month Prospective Study.Iranian journal of psychiatry · 2022Article
- Developing and validating a measurement tool to self-report perceived barriers in substance use treatment: the substance use treatment barriers questionnaire (SUTBQ).Substance abuse treatment, prevention, and policy · 2021Article
- Investigating the CYP2B6 rs3745274 and rs3211371 polymorphisms in Methadone-Responder and Non-Responder Addicts in Iran.Iranian biomedical journal · 2021Article
- Prevalence of Symptom-based Sexually Transmitted Infections and Related Factors among Incarcerated Men in Iran, 2013.Medical journal of the Islamic Republic of Iran · 2021Article
- Public Stigma Toward Female and Male Opium and Heroin Users. An Experimental Test of Attribution Theory and the Familiarity Hypothesis.Frontiers in public health · 2021Article
- A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- to middle-income setting.Harm reduction journal · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextIn the present review study, authors investigated Iran's activities regarding prevention, abuse and harm reduction of drugs nationwide. The issue appears to be important in order to show the trend of activities in the country. EVIDENCE ACQUISITION: In this report, authors gathered data from different Farsi/English peer review journals issued both in printed and online versions. These journals have been indexed in PubMed, ISI, ISC, SID, Magiran, UN, etc. These are among the most referred and cited databases.
resultsSummarizing the data led to three distinguished sections: 1) drug supply reduction activities; 2) drug demand reduction activities; 3) harm reduction activities.
conclusionsAs the results showed, the trend of activities was encouraging and some additional activities could be included to future programs relying on early-onset preventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.